Neuropathy may be prevented with an exercise program, and prostate cancer screening standards may not be appropriate for transgender women taking estrogen.

by Eric Fitzsimmons

The drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.

by Laura Gesualdi-Gilmore

Acupuncture helps manage side effects of endocrine therapy, and adding chemotherapy before surgery delays progression in pancreatic cancer.

by Marci A. Landsmann

FDA approval allows patients to collect samples for HPV test, lowering a barrier to an important cancer prevention tool.

by Taneia Surles

Risk for cancer and cardiovascular disease linked to air pollution, and three cancer drugs could face generic competition by 2028.

by Kevin McLaughlin

Lung cancer screening linked to lower mortality in real-world data, and researchers study unusual cancer patterns after COVID-19 infection.

by Eric Fitzsimmons

Researchers at the AACR Annual Meeting 2024 consider ways in which social and economic factors like location affect cancer risk and outcomes.

by Eric Fitzsimmons

Research supports reducing the intensity of cancer treatment, and barriers can prevent members of the LGBTQ+ community from receiving cancer screening and care.

by Thomas Celona

Cathy Nobil-Dutton did all the right things to protect her health, but a uterine cancer diagnosis showed her life doesn’t always go as expected.

by Cathy Nobil-Dutton

Young adults often ignore telltale signs of colorectal cancer, and more evidence supports active surveillance for low-risk prostate cancer.

by Marci A. Landsmann